We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Drug and device companies risk losing out on the competitive and regulatory advantages of electronic data capture (EDC) by failing to address their own corporate cultures, skimming over training efforts and failing to set clear goals before attempting to implement a program, experts told PIR last week.
Growing support for minimally invasive surgery combined with a growing elderly population will likely cause an increase in the use of heart stents in Europe, according to a recent study by consulting group Frost & Sullivan.
Drug sponsors that use contract research organizations (CROs) can speed up the drug development process without compromising research quality, according to a new study that finds CROs are playing an increasingly larger role in drug development.
Devicemaker Orthovita -- a biomaterials company specializing in developing products that restore fractured bones -- just selected MasterControl's integrated quality management suite to facilitate compliance with 21 CFR Part 11 and other FDA requirements.
Fonar’s Upright MRI provides more complete visualization of physical injuries than a recumbent-only MRI, according to a recent study conducted by Westchester Spine and Brain Surgery and Upright Imaging.
The market for peripheral vascular devices (PVDs) in the U.S. will grow by nearly $1 billion over the next five years, reaching annual sales of $2.6 billion in 2010, predicts a recent report by the Millennium Research Group.
Proponents of radio frequency identification (RFID) tags received a boost this month when Pfizer said it had begun shipping its first product, Viagra, with the tags embedded. Pfizer selected its popular erectile dysfunction drug for the pilot run because the drug has been a major target of counterfeiters, the company said recently.
Orthovita, a biomaterials company specializing in the development of products that help restore fractured bones, just selected Master-
Control's integrated quality management suite to facilitate compliance with 21 CFR Part 11 and other FDA requirements.
Proponents of radio frequency identification (RFID) tags received a boost earlier this month when Pfizer said it had begun to ship its first product – Viagra – with the tags embedded.
Despite the rise of regulatory demands governing electronic data, privacy, intellectual property protection and internal governance are also driving organizations to embrace new technologies that protect data "both at rest and in transit," says a new white paper from Proofpoint.